Study Charts rAAV Dose Costs by Indication and Identifies Cost-Cutting Strategies
Viral gene therapy’s manufacturing economics are being reshaped by a new indication-by-indication analysis of recombinant AAV (rAAV) costs and capacity ...
Viral gene therapy’s manufacturing economics are being reshaped by a new indication-by-indication analysis of recombinant AAV (rAAV) costs and capacity ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine